Navigation Links
Regeneron Announces September 2012 Investor Conference Presentations
Date:8/29/2012

TARRYTOWN, N.Y., Aug. 29, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast management presentations at the following investor conferences:

  • Robert W. Baird Healthcare Conference at 1:20 p.m. Eastern Time on Wednesday, September 5, 2012
  • Morgan Stanley Global Healthcare Conference at 3:55 p.m. Eastern Time on Tuesday, September 11, 2012
  • UBS Global Life Sciences Conference at 7:30 a.m. Eastern Time on Thursday, September 20, 2012
  • The sessions may be accessed through the Company's web site, www.regeneron.com, on the Events and Presentations page.  Archived versions of the presentations will be available for thirty days after the live webcasts. 

    Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets three products in the United States, EYLEA® (aflibercept) Injection, ZALTRAP® (ziv-aflibercept) Injection for Intravenous Infusion, and ARCALYST® (rilonacept) Injection for Subcutaneous Use.  Regeneron has filed a regulatory application with the U.S. Food and Drug Administration (FDA) for a second indication for EYLEA.  Phase 3 studies are in progress with EYLEA in two additional indications and with product candidates sarilumab and REGN727.  Regeneron has active research and development programs in many disease areas, including ophthalmology, inflammation, cancer, and hypercholesterolemia.  Additional information and recent news releases are available on the Regeneron web site at www.regeneron.com.Contact Information:Manisha Narasimhan, Ph.D.

    Peter DworkinInvestor Relations

    Corporate Communications914-847-5126

    914.847.764manisha.narasimhan@regeneron.com 

    peter.dworkin@regeneron.com


    '/>"/>
    SOURCE Regeneron Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
    2. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
    3. Regeneron Announces June 2012 Investor Conference Presentations
    4. Regeneron to Report Second Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on July 25, 2012
    5. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
    6. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
    7. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
    8. Misonix Announces New Distribution Agreement For Panama
    9. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
    10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
    11. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/11/2019)... ... November 11, 2019 , ... Over 60 schools in the northwest panhandle of ... program is designed to provide virtual mental health care to more than 35,000 students ... in October of 2018 [1]. , “This initiative by the state of Florida,” says ...
    (Date:11/11/2019)... ... November 11, 2019 , ... The Naderi Center in Chevy Chase, ... practice POS, point of sale, website for providing the highest level of care in ... Cosmetic Surgery Specialists uses advanced financial technology in their daily business transactions using the ...
    (Date:11/11/2019)... ... , ... The Advocator Group, LLC, part of Brown & Brown Inc., is ... in the Boston Globe Magazine. This recognition has been earned for the fourth consecutive ... 2014. , The rankings for the Top 100 Women-Led Businesses in each state ...
    Breaking Medicine Technology:
    (Date:11/12/2019)... ... November 12, 2019 , ... ... today announced that Tidewater Physicians Multispecialty Group (TPMG), a network of ... Outcomes® patient engagement platform to deliver enhanced patient experience and overall ...
    (Date:11/12/2019)... ... November 12, 2019 , ... Certemy, ... today announced the release of new features for custom branding. The new features ... emails to match their physical brand attributes. Customizable attributes include customer logo, an ...
    (Date:11/11/2019)... , ... November 11, 2019 , ... ... support services to dental groups in the United States, today announced the grand ... of Lodi, CA. , Patients will enjoy convenient hours, comfortable offices and full-service ...
    (Date:11/11/2019)... BIRMINGHAM, Ala. (PRWEB) , ... November 11, 2019 ... ... provider of urgent care, accessible primary care and occupational medicine, is expanding its ... relations company, to target and engage franchise candidates. With more than 200 locations ...
    (Date:11/11/2019)... ... November 11, 2019 , ... PracticeLink Live! Atlanta Physician Career Fair will ... begin at 5:00 p.m. and continue until 8:00 p.m. A free, optional seminar for ... begin at 6:30 p.m. , Both the career fair and seminar are open to ...
    Breaking Medicine News(10 mins):